Discover 1,883 paid clinical trials in Denton, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,883
Active & Responsive
Active Music-Based Intervention in Patients With Chronic Low Back Pain
for
Chronic Low Back Pain
Location: Denton TX
Sponsor: Sharon Wang-Price
Sex: All
Age: 18 - 65
Code: NCT06940063
Recruiting
Active & Responsive
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
Location: Denton TX, Greenfield WI, Scottsdale AZ,
Sponsor: Takeda
Sex: All
Age: 18+
Code: NCT06747351
Phase3, Recruiting
Active & Responsive
A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy
for
Spinal Muscular Atrophy (SMA)
Location: Flower Mound TX, Little Rock AR, Chicago IL,
Sponsor: argenx
Sex: All
Age: 5 - 17
Code: NCT07287982
Phase2, Recruiting
Active & Responsive
Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-101 in Participants With Myotonic Dystrophy Type 1
for
Myotonic Dystrophy Type 1 (DM1)
Location: Denton TX, St Louis MO, Iowa City IA, Indianapolis IN,
Sponsor: Dyne Therapeutics
Sex: All
Age: 18 - 65
Code: NCT05481879
Phase1, Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
for
NASH With Fibrosis, MASH With Fibrosis
Location: Lewisville TX, Dallas TX, Fort Worth TX, Denison TX,
Sponsor: Akero Therapeutics, Inc
Sex: All
Age: 18 - 70+
Code: NCT06215716
Phase3, Recruiting
Active & Responsive
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
for
Diabetes Mellitus, Type 2, PreDiabetes, Metabolic Syndrome
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity